Is type 2 diabetes mellitus associated with alterations in hearing? A systematic review and meta-analysis

Laryngoscope

Volumn 124, Issue 3, 2014, Pages 767-776

  Akinpelu, Olubunmi V ^a   Mujica Mota, Mario ^a   Daniel, Sam J ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

hearing function; meta analysis; systematic review; Type 2 diabetes

Indexed keywords

HEARING FUNCTION; META-ANALYSIS; SYSTEMATIC REVIEW; TYPE 2 DIABETES;

AGE DISTRIBUTION; AGED; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; FEMALE; HEARING DISORDERS; HEARING LOSS; HEARING TESTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 84894446208     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24354     Document Type: Review

References (80)

1. National Diabetes Fact Sheet. Available at: http://www.cdc.gov/diabetes. Accessed January 5, 2013.
2. WHO. Prevention of diabetes mellitus. Geneva, Switzerland: World Health Organization, 1994.
3. Cano JF, Baena-Diez JM, Franch J, et al. Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe. Diabetes Care 2010; 33: 2004-2009.
4. Diabetes statistics. Available at: http://www.diabetes.org/diabetes- basics/diabetes-statistics. Accessed December 22, 2012 2012.
5. Szalat A, Raz I,. Metabolic syndrome and microangiopathy. Isr Med Assoc J 2006; 8: 424-425.
6. Roy S, Trudeau K, Roy S, Behl Y, Dhar S, Chronopoulos A,. New insights into hyperglycemia-induced molecular changes in microvascular cells. J Dent Res 2010; 89: 116-127.
7. Ammary-Risch NJ, Huang SS,. The primary care physician's role in preventing vision loss and blindness in patients with diabetes. J Natl Med Assoc 2011; 103: 281-283.
8. Velez R, Tyler M, Chen J, Babcock M, Moran WP,. Project I See in NC: Initial results of a program to increase access to retinal examinations among diabetic individuals in North Carolina. N C Med J 2011; 72: 360-364.
9. VanGuilder HD, Bixler GV, Kutzler L, et al. Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. PloS One 2011; 6: e16271.
10. Helfenstein T, Fonseca FA, Ihara SS, et al. Impaired glucose tolerance plus hyperlipidaemia induced by diet promotes retina microaneurysms in New Zealand rabbits. Int J Exp Pathol 2011; 92: 40-49.
11. Netten PM, Wollersheim H, Thien T, Lutterman JA,. Skin microcirculation of the foot in diabetic neuropathy. Clin Sci (Lond) 1996; 91: 559-565.
12. Toth C, Martinez J, Zochodne DW,. RAGE, diabetes, and the nervous system. Curr Mol Med 2007; 7: 766-776.
13. Chao CY, Cheing GL,. Microvascular dysfunction in diabetic foot disease and ulceration. Diabetes Metab Res Rev 2009; 25: 604-614.
14. Guerci B, Kearney-Schwartz A, Bohme P, Zannad F, Drouin P,. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function. Diabetes Metab 2001; 27: 425-434.
15. Taslipinar A, Yaman H, Yilmaz MI, et al. The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy. Scand J Clin Lab Invest 2011; 71: 606-612.
16. Nakae S, Tachibana M,. The cochlea of the spontaneously diabetic mouse. II. Electron microscopic observations of non-obese diabetic mice. Arch Otorhinolaryngol 1986; 243: 313-316.
17. Raynor E, Robison WG, Garrett CG, McGuirt WT, Pillsbury HC, Prazma J,. Consumption of a high-galactose diet induces diabetic-like changes in the inner ear. Otolaryngol Head Neck Surg 1995; 113: 748-754.
18. Fukushima H, Cureoglu S, Schachern PA, et al. Cochlear changes in patients with type 1 diabetes mellitus. Otolaryngol Head Neck Surg 2005; 133: 100-106.
19. Jorgensen MB,. The inner ear in diabetes mellitus. Histological studies. Arch Otorhinolaryngol 1961; 74: 373-381.
20. Falbe-Hansen J,. Histochemical Studies on Glycogen in the Cochlea of Drug-Injected Guinea Pigs and Alloxan-Diabetic White Rats. Acta Otolaryngol Suppl 1964; 188: 108+.
21. Makishima K, Tanaka K,. Pathological changes of the inner ear and central auditory pathway in diabetics. Ann Otol Rhinol Laryngol 1971; 80: 218-228.
22. Axelsson A, Sigroth K, Vertes D,. Hearing in diabetics. Acta Otolaryngol Suppl 1978; 356: 1-23.
23. Ishii EK, Talbott EO, Findlay RC, D'Antonio JA, Kuller LH,. Is NIDDM a risk factor for noise-induced hearing loss in an occupationally noise exposed cohort? Sci Total Environ 1992; 127: 155-165.
24. Cullen JR, Cinnamond MJ,. Hearing loss in diabetics. J Laryngol Otol 1993; 107: 179-182.
25. Harner SG,. Hearing in adult-onset diabetes mellitus. Otolaryngol Head Neck Surg 1981; 89: 322-327.
26. Hodgson MJ, Talbott E, Helmkamp JC, Kuller LH,. Diabetes, noise exposure, and hearing loss. J Occup Med 1987; 29: 576-579.
27. Horikawa C, Kodama S, Tanaka S, et al. Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol Metab 2013; 98: 51-58.
28. WHO. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organisation, 1999.
29. Clark JG,. Uses and abuses of hearing loss classification. ASHA 1981; 23: 493-500.
30. Jerger J, Mauldin L,. Prediction of sensorineural hearing level from the brain stem evoked response. Arch Otolaryngol 1978; 104: 456-461.
31. Kavanagh KT, Beardsley JV,. Brain stem auditory evoked response. Ann Otol Rhinol Laryngol Suppl 1979; 88: 1-28.
32. Burkard RF, Manuel D, Eggermont JJ,. Auditory evoked potentials: basic principles and clinical application. Philadelphia, PA: Lippincott Williams & Wilkins, 2007.
33. Downs SH, Black N,. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384.
34. Sakuta H, Suzuki T, Yasuda H, Ito T,. Type 2 diabetes and hearing loss in personnel of the Self-Defense Forces. Diabetes Res Clin Pract 2007; 75: 229-234.
35. Dalton DS, Cruickshanks KJ, Klein R, Klein BE, Wiley TL,. Association of NIDDM and hearing loss. Diabetes Care 1998; 21: 1540-1544.
36. Mitchell P, Gopinath B, McMahon CM, et al. Relationship of Type 2 diabetes to the prevalence, incidence and progression of age-related hearing loss. Diabet Med 2009; 26: 483-488.
37. Sasso FC, Salvatore T, Tranchino G, et al. Cochlear dysfunction in type 2 diabetes: a complication independent of neuropathy and acute hyperglycemia. Metabolism 1999; 48: 1346-1350.
38. Gupta R, Aslam M, Hasan S, Siddiqi S,. Type -2 diabetes mellitus and auditory brainstem responses-a hospital based study. Indian J Endocrinol Metab 2010; 14: 9-11.
39. Pozzessere G, Rizzo PA, Valle E, et al. Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control. Diabetes Care 1988; 11: 473-480.
40. Talebi M, Moosavi M, Mohamadzade NA, Mogadam R,. Study on brainstem auditory evoked potentials in diabetes mellitus. Neurosciences (Riyadh) 2008; 13: 370-373.
41. Diaz de Leon-Morales LV, Jauregui-Renaud K, Garay-Sevilla ME, Hernandez-Prado J, Malacara-Hernandez JM,. Auditory impairment in patients with type 2 diabetes mellitus. Arch Med Res 2005; 36: 507-510.
42. Kurt E, Ozturk F, Gunen A, et al. Relationship of retinopathy and hearing loss in type 2 diabetes mellitus. Ann Ophthalmol 2002; 34: 216-222.
43. Mozaffari M, Tajik A, Ariaei N, Ali-Ehyaii F, Behnam H,. Diabetes mellitus and sensorineural hearing loss among non-elderly people. East Mediterr Health J 2010; 16: 947-952.
44. Austin DF, Konrad-Martin D, Griest S, McMillan GP, McDermott D, Fausti S,. Diabetes-related changes in hearing. Laryngoscope 2009; 119: 1788-1796.
45. Aladag I, Eyibilen A, Guven M, Atis O, Erkokmaz U,. Role of oxidative stress in hearing impairment in patients with type two diabetes mellitus. J Laryngol Otol 2009; 123: 957-963.
46. Bamanie AH, Al-Noury KI,. Prevalence of hearing loss among Saudi type 2 diabetic patients. Saudi Med J 2011; 32: 271-274.
47. Panchu P,. Auditory acuity in type 2 diabetes mellitus. Int J Diabetes Dev Ctries 2008; 28: 114-120.
48. El-Naggar M, Aziz FK, Holi EA, Quraishi MZ, Hashlamoun M,. Hearing ioss and diabetes in a United Arab Emirates population: a prospective controlled study. Emirates Medical Journal 2003; 21: 152-154.
49. Acuna Garcia M, Herrero Laso JL, Duran Diez C, et al. [Diabetic complications and hypoacusia]. An Otorrinolaringol Ibero Am 1997; 24: 465-476.
50. Anandhalakshmi S, Rajendran S, Mythili M,. Evaluation of the auditory effects of hyperlipidaemia and diabetes mellitus by using audiometry. J Clin Diagn Res 2011; 5: 1528-1532.
51. Gupta S, Baweja P, Mittal S, Kumar A, Singh KD, Sharma R,. Brainstem auditory evoked potential abnormalities in type 2 diabetes mellitus. N Am J Med Sci 2013; 5: 60-65.
52. Ma F,. Diabetes and hearing impairment in Mexican American adults: a population-based study. J Laryngol Otol 1998; 112: 835-839.
53. Wake M, Tobin S, Cone-Wesson B, et al. Slight/mild sensorineural hearing loss in children. Pediatrics 2006; 118: 1842-1851.
54. Ciorba A, Benatti A, Bianchini C, et al. High frequency hearing loss in the elderly: effect of age and noise exposure in an Italian group. J Laryngol Otol 2011; 125: 776-780.
55. Gordon-Salant S,. Hearing loss and aging: new research findings and clinical implications. J Rehabil Res Dev 2005; 42: 9-24.
56. Sha SH, Kanicki A, Dootz G, et al. Age-related auditory pathology in the CBA/J mouse. Hear Res 2008; 243: 87-94.
57. Gratton MA, Schmiedt RA, Schulte BA,. Age-related decreases in endocochlear potential are associated with vascular abnormalities in the stria vascularis. Hear Res 1996; 102: 181-190.
58. Huang Q, Tang J,. Age-related hearing loss or presbycusis. Eur Arch Otorhinolaryngol 2010; 267: 1179-1191.
59. Jorgensen MB, Buch NH,. Studies on inner-ear function and cranial nerves in diabetics. Acta Otolaryngol 1961; 53: 350-364.
60. Helzner EP, Cauley JA, Pratt SR, et al. Race and sex differences in age-related hearing loss: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2005; 53: 2119-2127.
61. Kim S, Lim EJ, Kim HS, Park JH, Jarng SS, Lee SH,. Sex differences in a cross sectional study of age-related hearing loss in Korean. Clin Exp Otorhinolaryngol 2010; 3: 27-31.
62. Bansal V, Kalita J, Misra UK,. Diabetic neuropathy. Postgrad Med J 2006; 82: 95-100.
63. Kovar M,. The inner ear in diabetes mellitus. ORL J Otorhinolaryngol Relat Spec 1973; 35: 42-51.
64. Sonneville R, den Hertog HM, Guiza F, et al. Impact of hyperglycemia on neuropathological alterations during critical illness. J Clin Endocrinol Metab 2012; 97: 2113-2123.
65. Malone JI, Hanna S, Saporta S, et al. Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr Diabetes 2008; 9: 531-539.
66. Ola MS, Nawaz MI, El-Asrar AA, Abouammoh M, Alhomida AS,. Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats. Cell Mol Neurobiol 2013; 33: 359-367.
67. Fritzsch B, Silos-Santiago I, Bianchi LM, Farinas I,. The role of neurotrophic factors in regulating the development of inner ear innervation. Trends Neurosci 1997; 20: 159-164.
68. Ernfors P, Van De Water T, Loring J, Jaenisch R,. Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 1995; 14: 1153-1164.
69. Krabbe KS, Nielsen AR, Krogh-Madsen R, et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007; 50: 431-438.
70. Fujinami A, Ohta K, Obayashi H, et al. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem 2008; 41: 812-817.
71. Hinder LM, Vincent AM, Burant CF, Pennathur S, Feldman EL,. Bioenergetics in diabetic neuropathy: what we need to know. J Peripher Nerv Syst 2012; 17 (suppl 2): 10-14.
72. Brownlee M,. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
73. Vincent AM, Olzmann JA, Brownlee M, Sivitz WI, Russell JW,. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes 2004; 53: 726-734.
74. Tomlinson DR, Gardiner NJ,. Diabetic neuropathies: components of etiology. J Peripher Nerv Syst 2008; 13: 112-121.
75. Kurien M, Thomas K, Bhanu TS,. Hearing threshold in patients with diabetes mellitus. J Laryngol Otol 1989; 103: 164-168.
76. Kasemsuwan L, Sriwanyong S, Krittiyawong S, Sunetrworakul J, Jiamsuchon K,. Hearing in young diabetic patients. J Med Assoc Thai 2001; 84: 1389-1394.
77. Axelsson A, Fagerberg SE,. Auditory function in diabetics. Acta Otolaryngol 1968; 66: 49-64.
78. Tay HL, Ray N, Ohri R, Frootko NJ,. Diabetes mellitus and hearing loss. Clin Otolaryngol Allied Sci 1995; 20: 130-134.
79. Agarwal MK, Jha AK, Singh SK,. Otorhinolaryngological studies in diabetics. Indian J Otolaryngol Head Neck Surg 1998; 50: 116-121.
80. Hall J,. New handbook of auditory evoked responses. Boston, MA: Allyn and Bacon, 2006.